Skip to content
Regulus Therapeutics logo

Regulus Therapeutics Alternatives & Competitors

12 companies similar to Regulus Therapeutics

Companies similar to Regulus Therapeutics

ExcepGen logo — alternative to Regulus Therapeutics

ExcepGen

Solving fundamental problems in drug discovery to create a new generation of therapeutics.

Telesis Bio logo — alternative to Regulus Therapeutics

Telesis Bio

Accelerating the path from AI-driven design to physical biology.

Certa Therapeutics logo — alternative to Regulus Therapeutics

Certa Therapeutics

Developing innovative precision therapies for the treatment of inflammatory and fibrotic d...

Atomwise logo — alternative to Regulus Therapeutics

Atomwise

Better Medicines Faster

Rival Readout

Competing with Regulus Therapeutics? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Eli Lilly and Company logo — alternative to Regulus Therapeutics

Eli Lilly and Company

Discovery, development, manufacture, and sale of products in pharmaceutical products busin...

Nereus Pharmaceuticals logo — alternative to Regulus Therapeutics

Nereus Pharmaceuticals

Pioneering marine microbiology to develop advanced treatments for cancer, infections, and...

Elastrin Therapeutics logo — alternative to Regulus Therapeutics

Elastrin Therapeutics

Using drug-loaded nanoparticles for the effective treatment of life-threatening diseases

Escient Pharmaceuticals logo — alternative to Regulus Therapeutics

Escient Pharmaceuticals

Targeted therapeutics for neurosensory-inflammatory disorders

Expansion Therapeutics logo — alternative to Regulus Therapeutics

Expansion Therapeutics

Bringing transformative therapies to patients with severe RNA-mediated diseases.

Sitryx logo — alternative to Regulus Therapeutics

Sitryx

Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...

Rona Therapeutics logo — alternative to Regulus Therapeutics

Rona Therapeutics

Empower Great People To Do Great Things

Disc Medicine logo — alternative to Regulus Therapeutics

Disc Medicine

Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patien...

About Regulus Therapeutics

Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company based in San Diego, California, founded in 2007. The company specializes in developing innovative medicines targeting microRNAs, with a focus on leveraging its expertise in oligonucleotide drug discovery.

Business keywords

Biopharmaceutical, Drug Discovery, MicroRNA Therapeutics, Oligonucleotide, Biomarkers, Intellectual Property, San Diego, Executive Team, Scientific Advisory Board, Life Sciences, MicroRNA Research, Gene Expression, Innovation

Frequently Asked Questions

Companies similar to Regulus Therapeutics include ExcepGen, Telesis Bio, Certa Therapeutics, Atomwise, Eli Lilly and Company. They work in Biotechnology and Health Care and share Regulus Therapeutics's focus on drug discovery, life sciences and biopharmaceutical.
Bounce Watch lists 12 companies that share Regulus Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.
Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company based in San Diego, California, founded in 2007. The company specializes in developing innovative medicines targeting microRNAs, with a focus on leveraging its expertise in oligonucleotide drug discovery.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Regulus Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Regulus Therapeutics on 11 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 5 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout